View all veterinary jobs
VetSurgeon.org publishes a curated feed of veterinary news for practising veterinary surgeons, with a primary focus on the UK profession.
We select stories based on their practical relevance, clinical interest, or professional significance — filtering out noise so busy vets can stay informed quickly.
Our coverage includes:
We report across all areas of practice, including companion animal, farm, equine and exotic species.
Our editorial approach is deliberately selective and concise. We prioritise clarity and relevance over volume, aiming to make each story worth your time.
You can follow VetSurgeon News by subscribing to the daily, weekly or monthly email digest, or via our channels on Facebook and LinkedIn.
Zoetis has announced that following a positive opinion from the Committee for Medicinal Products for Veterinary Use (CVMP), the European Commission has approved Apoquel (oclacitinib tablet) in the European Union for the treatment of pruritus associated with allergic dermatitis and the treatment of clinical manifestations of atopic dermatitis in dogs at least 12 months of age.
Developed by Zoetis, Apoquel is the first Janus kinase (JAK) inhibitor approved for veterinary use. The company says it inhibits the function of a variety of allergic, itch and pro-inflammatory cytokines dependent on JAK enzyme activity and thus stops the cycle of itch and inflammation occurring in skin allergies.
Michael Stegemann, Senior Director Global Development Organisation at Zoetis said: "Apoquel is a targeted treatment that specifically inhibits JAK-dependent cytokines involved in allergic skin disease in dogs. Its rapid anti-pruritic effect along with its anti-inflammatory properties provide fast relief to dogs. Relief from itch and inflammation is maintained in dogs receiving long-term treatment with Apoquel. This exciting innovation molecule offers quick, effective, and sustained itch relief; improves skin lesions continuously and can be used safely short or long-term."
Zoetis says that in clinical trials, Apoquel demonstrated safety and efficacy for the treatment of itch and resulted in improved skin lesions in dogs diagnosed with a number of allergic skin diseases as well as atopic dermatitis and treated either short or long term. The decrease in itch scores was observed by pet owners as soon as 24 hours after administration, the first observation time point, and itch continued to decrease compared to baseline until the end of the study. Skin lesions scores assessed by veterinary surgeons were significantly improved after one week and continued to improve long term during the studies (4 months). In these studies, the most common side effects observed in dogs treated with Apoquel were vomiting and diarrhea. Other reported side effects included lethargy, decreased or lack of appetite, skin irritation or infection, and ear irritation or infection.
Apoquel will be a POM-V treatment. Apoquel tablets, dosed at 0.4 to 0.6 mg/kg, are administered orally, twice daily for up to 14 days, and then administered once daily for maintenance therapy if medium to long term treatment is required, such as in dogs with seasonal skin allergy and atopic dermatitis.
Zoetis plans to make Apoquel available to veterinary surgeons in the European Union during 2014. Meantime, Zoetis says it will be working with vets on the new science and research findings around itch and canine allergic diseases. For more information, visit www.zoetis.com, www.itchcycle.com.
The pack highlights the benefits of Adaptil and Feliway and Ceva’s ThunderShirt range of calming wraps.
It contains a wall/notice board display, a poster, an e-book and leaflet for owners, and a social media toolkit with graphics and pre-written posts for practices to use on their own social media channels.
The company is also running its fireworks waiting room display competition this month, in which the five veterinary practices who make best use of the materials for creating a display in their waiting room will win one of five £100 Love 2 Shop vouchers.
There are bonus points for practices that build a den in the waiting room to demonstrate the benefits of having a safe haven for dogs to retreat to when fireworks are going off.
Veterinary professionals can post pictures of the dens and waiting room displays on the Adaptil Facebook page throughout October - www.facebook.com/AdaptilForDogs.
Ceva is running commercial offers in the run up to the firework season, which practices are being encouraged to pass to their clients.
To download the fireworks marketing support pack go to http://bit.ly/3RxGLza.
For further information, contact your Ceva territory manager or email cevauk@ceva.com.
The first is Design Hub, a self-service marketing portal which allows practices to choose from a variety of designs for posters, social media posts and other collateral and brand them with the practice logo. The portal includes a planner which details noteworthy dates, veterinary campaigns and events that practices might want to include in their marketing plans.
Member practices using the new portal during February also have the chance to enter a competition to win £500 Love2shop vouchers.
The second resource is a pets portal which the company says will make it easier to access live information about pets enrolled on its health plans, make administrative changes, process refunds or cancellations and soon, add new pets.
From July the pets portal will compatible with tablets and other mobile devices, so practice staff can move out from behind the desk and have conversations with pet owners in the waiting or consulting rooms.
Paul Bates, Practice Development Specialist, said: "We had already identified that practices wanted to be able to register plans and change details online. It was important for us to also ensure that the tool we developed had the desired functionality and was robust enough to handle large volumes of data being entered simultaneously across the country.
"We also wanted it to be fit for purpose so that if we want to develop more advanced features going forwards, we don’t have to recreate the wheel and can build on what we have already. The portal will be really useful in its own right and gives us a great launching pad for future development."
To access the new portals, email: pethealthplanscomms@denplan.co.uk, or contact your Simplyhealth Professionals Practice Support Advisor or Business Development Consultant.
For more information about Simplyhealth Professionals visit http://www.pethealthplans.co.uk/vets.
The Vet Wellbeing Awards, which are now in their fourth year, are designed to highlight positivity within the profession by sharing stories and initiatives from veterinary workplaces that demonstrate commitment to improving staff wellbeing.
The Awards also aim to support all practices to take a structured approach towards evaluating their own wellbeing support systems.
This year, for the first time, feedback will be given to practices that enter about the areas where they are doing well and those where they can improve. The organisers hope that this change to the Awards process will encourage practices to think of wellbeing support as an area of continuous development.
However, they also hope that practices will use the entry process as an opportunity to audit wellbeing even if they don't plan to enter.
Liz Barton, SPVS Board Member, said: "Going through the entry form and evaluation process is valuable for every vet practice, even if they don’t feel they’re ready to enter the Awards just yet. Sitting down as a practice team for a few hours and working through the questionnaire is a highly useful exercise for facilitating celebrating areas where your practice is doing well for wellbeing, and also highlighting some areas for improvement for years to come."
"We recommend all practices get into the habit of going through the process annually and choosing areas to focus and improve on, to build towards better wellbeing across all areas for all staff."
There are three award categories that practices can enter depending on the number of employees: small practice (15 or fewer full time equivalent team members (FTE)), medium practice (16 to 50 FTEs) or large practice (51 or FTEs).
The Award application form covers six aspects of work that, if well-managed, can promote wellbeing and reduce the risk of work-related stress, and the Award judges will be looking for evidence of commitment to enhancing wellbeing for each of these.
They are:
Promoting physical and psychological health at work
Relationships at work
Communication at work
Career development
Workload and work scheduling
Work demands
More examples of the type of evidence and initiatives that the Awards are looking for, together with the entry form, are available on the Vet Wellbeing Awards website: https://vetwellbeingawards.org.uk.
Winning and Highly Commended practices will receive a dedicated logo and certificate for display. The winners in each category will also receive two registrations and banquet tickets for SPVS/VMG Congress 2020.
In addition to the Wellbeing Awards, the RCVS and SPVS are also running the Practice Star nominations, which are open to all veterinary practices.
These nominations aim to support practices to thank someone in their team who has gone the extra mile to make the practice a happy place to work, whether this be through introducing an initiative that makes everyone’s work life better, going out of their way to support a colleague going through a tough time, or just making everyone smile.
To enter, practices need to send in their nominee’s name, job title and contact details, and a short paragraph explaining why they have been chosen. They will then receive a certificate congratulating them for being nominated as the practice’s very own ‘Practice Wellbeing Star’.
The closing date for both the Wellbeing Award entries and Practice Star nominations is Friday 22 November 2019.
Michale Garvey (pictured) has the official title of National Property Coordinator and he will work with local surveyors to ensure that landlords have realistic expectations supported by evidence at rent reviews and lease renewals.
VLA Treasurer Nicky Paull said: "This should help speed up what are sometimes protracted and expensive negotiations to the mutual benefit of corporate tenant and landlord alike.”
Michael is a Chartered Surveyor who has worked in the commercial property sector for 35 years.
He is the Managing Director of Chandler Garvey, a Fellow of both the Royal Institution of Chartered Surveyors and the Chartered Institute of Arbitrators, as well as being an RICS Registered Valuer.
He has specialised in rent reviews and lease renewals all of his career and has been a member of the RICS Arbitrators Panel for more than 10 years.
Michael also has extensive experience of the veterinary sector, having represented owners relating to disputed rent reviews, as well as acquisitions and lettings on different types of premises.
He said: “I am delighted to have been appointed by the VLA as the National Property Coordinator, with the intention of allowing the owners of veterinary premises, to have a better understanding of the rent review and lease renewal processes and in doing so even the playing field so that better outcomes are achieved.
Richard Hillman one of the VLA’s founders said: “Negotiating with large corporate groups can sometimes feel like trying to run through treacle for small landlords.
"Having an acknowledged expert on our team should help the VLA to give much needed support to our members.”
Further information about the VLA can be obtained from Richard Stephenson vicechair@vla.org.uk
https://vla.org.uk
Merial has announced the launch of Viral Cats, a national campaign designed to educate one million cat owners about the importance of vaccination.
According to PDSA research, approximately 3.9 million cats in the UK are not up to date with their vaccinations and around 2.7 million cats have never been vaccinated1.
As part of the campaign, Merial is pushing a series of animations to cat owners via Facebook, which link to the campaign website: www.viralcats.co.uk. The website offers detailed information about the importance of vaccination and interactive content including a 'risk checker' quiz.
The 'risk checker' quiz will ask owners a series of questions to find out whether their cat is up to date with its vaccinations. If not, they'll be directed to speak to their vet. If the vet recommends restarting the primary vaccination course, owners will be able to download an amnesty voucher – directing them to participating practices to get their pet back on track. For those who are up-to-date with their cat’s vaccinations, but want to help spread the word, there will be a competition and prize.
Aiz Baig, product manager at Merial, said: "This campaign is really exciting for Merial, offering us a great opportunity to reach and educate cat owners on the importance of vaccination, which of course will drive footfall into practices."
There are several ways veterinary practices can get involved with the campaign:
To find out more about the campaign, or take part, contact your regional Merial Territory Manager.
References:
The course is aimed at veterinary professionals across Europe who want to advance their knowledge and diagnostic skills, progress their academic qualifications and gain recognition in their field.
The GPAdvCert in Small Animal Medicine is for veterinary surgeons who have already completed a General Practitioner Certificate in Small Animal Medicine (GPCertSAM) or a Postgraduate Certificate (PgC) in Small Animal Medicine.
Accredited by the European School of Veterinary Postgraduate Studies (ESVPS) and validated by Harper Adams University, the programme will be delivered in three, five-day blocks of training by globally recognised experts in three European training centres - Sheffield, UK; Porto, Portugal and Berlin, Germany. The programme includes a practical session in which delegates will perform an upper and lower gastrointestinal endoscopy under the guidance of their tutor.
David Babington MRCVS, Business Development Director of Improve International (pictured right), said: "Delegates attending our first GPAdvCert in Small Animal Medicine will enhance their skills and confidence in dealing with complex animal medicine cases. Each module will take their knowledge beyond Postgraduate Certificate level with more in-depth and advanced content covering topics as diverse as mycobacterial and ureteric disease. They will also learn how to design a detailed diagnostic plan and build an understanding of nuances in interpreting laboratory findings to enable them to manage cases requiring complex therapeutic management with confidence."
He added: "The qualification is a natural ‘next-step’ for veterinary surgeons wanting to further progress their knowledge of small animal internal medicine. It will help them to reduce the number of patients which are referred, retaining a higher level of income for their practice and will also provide them with skills which they can pass onto their team."
Improve says the successful achievement of the GPAdvCert will enable delegates to progress from a Postgraduate Certificate in Small Animal Medicine (or equivalent) to the Postgraduate Diploma in Advanced Veterinary Practice Sciences in the UK, which is awarded by Harper Adams University. This can, in turn, be used towards the award of a Masters Degree (MSc) in Advanced Veterinary Practice Sciences.
RSPCA Chief Veterinary Officer, Caroline Allen, today praised the vets and nurses who are providing essential care to animals through the crisis.
She said: “This is an incredibly challenging time for the RSPCA, trying to advise the public and keeping emergency services going with fewer staff, strained resources and in line with Government advice.
"I know this is equally stressful and challenging for vet staff too and I wanted to say a huge thank you from everyone at the RSPCA for your hard work, dedication and support you are giving the RSPCA.
"Our call centre team and officer are working hard to maintain a frontline animal welfare service, but we know there may be occasions where we are unable to attend and this may impact demand on the local vet practice."
Current guidance from the BVA defines emergency and urgent treatment as:
Caroline continued: "There are some circumstances particular to the RSPCA, such as animals that have been subject to abuse or severe neglect, or injured/unwell unowned animals, that may not initially appear to be such an “emergency” in the traditional sense, but our officers will only be collecting them if there is considered to be ‘significant impact on health/welfare and likely to deteriorate if left unmanaged’ as covered by the BVA emergency criteria. We would greatly appreciate your support in ensuring we can protect the welfare of these animals.
"Our National Control Centre will also be following the guidance from the BVA and will be limiting, wherever possible, sending members of the public to vets. However, on occasions where there is a welfare need that would justify an essential journey, we will always ask members of the public to call practices first and follow their social distancing protocols.
"For vets who provide care for our shelters and private boarders we understand the support available will be limited, we will be producing further advice for our teams around options, including remote support.
"We do understand and appreciate the current restrictions being put in place by the BVA and we do understand the very serious strain on practices and teams at this time and we hope that we can continue to work together during this unprecedented time."
For the study, the RVC interviewed 13 small animal general practitioners, exploring their experience of providing pre-purchase consultations for brachycephalic dogs.
The study revealed a number of barriers to delivering effective pre-purchase consultations and advice about these breeds.
They included limited time and resources, competition for appointment availability, a perception that vets are only there to fix things, public distrust of veterinary surgeons (often over money), fear of damaging vet-client relationships, and the conflicting influence of breeders and the Kennel Club on clients.
Many veterinary surgeons that took part in the research felt that they had little or no power to overcome these barriers which are highly intractable at an individual veterinarian level.
A resulting moral conflict in veterinary surgeons between their perceived ethical and moral responsibilities to animal welfare versus the needs and wants of their clients and businesses was expressed by many vets in the study, and was felt to compromise their professional integrity and autonomy.
The study set out a series of recommendations:
Dr Rowena Packer, Lecturer in Companion Animal Behaviour and Welfare Science at the RVC and lead author of the study, said: “This is the first time that the impact of brachycephaly on the practising veterinary surgeon has been explored.
"Our concerning results highlight the importance of recognising that the brachycephalic crisis is not only negatively impacting animals, but it is affecting human wellbeing too.
“Our study highlights the conflict that vets are experiencing - bound both by their duty of care to their brachycephalic patients, but also to animal welfare at a population level.
"Trying to balance both of these responsibilities in the current working environment is proving very challenging for some, leading to moral distress.
"It is, therefore, essential that we protect the mental wellbeing of vets on this issue as well as from an animal welfare perspective.
“As the brachycephalic crisis continues to prevail, the support of leading veterinary organisations is vital in providing a united voice regarding the known harms of brachycephaly and support in facilitating PPCs to ensure vets are protected, and potential owners are fully informed when it comes to acquiring decisions.”
Dr Dan O’Neill, Assoc Prof of Companion Animal Epidemiology at the RVC and co-author of the study, said:
“Over the past decade, the RVC has generated a vast evidence base revealing the true extent of the serious health issues of dogs with brachycephaly.
"This new study now focuses RVC research towards protecting the wellbeing of practising veterinary surgeons who are also shown as victims of the brachycephalic crisis.
"The clear message here is that we all need to ‘stop and think before buying a flat-faced dog’.”
Woodley Equipment Company has announced that Veterinary Parasep Faecal Filters are now available exclusively from the company.
According to the Woodley, the filters have been developed in conjunction with an independent leading veterinary Institution and offer an improved method of determining Worm Egg Counts (WEC) on cattle, sheep and horses. Flotation methods for WEC can require several Specific Gravity solutions to cover different parasites. The two common flotation methods, ‘Modified McMaster' and ‘Improved Modified McMaster', both use Saturated NaCL and are both catered for with Veterinary Parasep.
Woodley says the key advantages of the new filters are:
For a more information about The Veterinary Parasep please email sales@woodleyequipment.com or call the customer service team on +44 (0) 1204 669033 ~ Option 1.
Alternatively, visit http://www.woodleyequipment.com/.
The dentistry group is one of a number of special interest groups being launched on VetSurgeon.org in the coming months which ALL members are invited to come and join.
The new groups make it much easier to find and follow content that interests you. More than that, they bring together members with a shared interest in the subject, thereby facilitating the sharing of information, experience and knowledge. To that end, expert contributors to the new dentistry group include: Pete Southerden, Norman Johnston, Bob Partridge and Evelyn Barbour-Hill.
As elsewhere on VetSurgeon.org, reading content in the new groups or participating in discussions can count towards a VetSurgeon.org CPD certificate. Just press 'Claim CPD' at the top of the page, then collect the record and certificate from your profile.
As elsewhere on VetSurgeon.org, there's also the opportunity for you to express your appreciation of shared information you've found helpful, by pressing the 'Thank you' button above content. We'll be rewarding those members who are most thanked by members of the site for their help.
The new groups have been set up partly in response to the growth in Facebook groups for vets and the need for VetSurgeon.org to offer added value over Facebook if it is to compete for your attention.
By virtue of the number of its numbers, Facebook probably can't be beaten for general 'chit chat'. But for clinical discussions, it has some serious flaws.
Firstly, there's minimal curation of content and it's more or less impossible to filter irrelevant stuff. Because of that, and because Facebook displays post excepts, rather than headlines, you can end up having to scroll as far as Australia to find stuff relating to your area of interest.
By contrast, the listings of latest content by title on VetSurgeon makes it much easier to scan the content and find the stuff that interests you, particularly now content is grouped by clinical discipline.
Perhaps even more importantly, it's impossible to see the professional qualifications of the person who replied to you on Facebook, so you don't necessarily know if they have the faintest idea what they are talking about. VetSurgeon profiles are visible to all, and allow members to display their postgrad veterinary qualifications, amongst other things.
Lastly, the way discussions on Facebook are 'threaded' makes it very, very difficult to refer back and find who said something useful (you remember someone said something, but then, on a busy thread, you may have to expand 20 or 20 threads to find the thing you were after). That's not just a pain in the derrière, it means that any valuable information shared by specialists and experts is too easily lost.
The bottom line is that if you're looking for general chat, Fleecebook may be your best bet. But if you have questions about specific clinical disciplines, VetSurgeon.org is where you'll find better answers, quicker.
The new service is being headed by Dr Katia Marioni-Henry.
Katia graduated from the University of Parma in 1995 and went on to do a PhD in Clinical Electrodiagnostic at the University of Turin and Scott-Ritchey Research Center in Auburn, Alabama.
Her early career was spent at various American universities, where she became a Diplomate of the American College of Veterinary Internal Medicine, with a subspecialty in Neurology and finally an Assistant Professor of Neurology and Neurosurgery at the University of Tennessee.
Katia came to the UK to work as a consultant in neurology and neurosurgery for a number of large referral practices, before moving to the University of Edinburgh in 2013, where she started the neurology/neurosurgery service, building it from scratch to a nine-strong team.
Katia said: “This is absolutely the best place to be brought in an emergency, but previously we’d have to refer some cases elsewhere for conditions affecting the brain, peripheral nerves or the spine.
“Now some of these debilitating neurological conditions can be diagnosed and treated rapidly here without having to transport the animal.”
“With our CT scanner, for example, we can diagnose slipped discs quickly, especially in small breeds, and treat them surgically.
“And we can use it for brain scans if there is trauma or if we suspect a tumour or severe inflammation in the brain.
“We can do a lumbar tap to rule out inflammation of the central nervous system either on infectious or immune-mediated basis.”
UK veterinary surgeons strongly prefer recommending branded treatments, according to a survey conducted by specialist advertising agency Masius.
The survey, conducted amongst members of www.vetsurgeon.org, received 725 responses. It gave a conclusive insight to veterinary surgeons' opinions on branding, with 87% of respondents saying that they prefer to recommend a branded POM-V over a generic equivalent.
While branded treatments are clearly preferred over generics, vets recognise that higher prices can be an issue for clients. Price is justified mainly through a higher level of trust in the quality of the product (through extensive trialling). They also cite the added support in the event of client usage issues and the value that clients attach to brands. The cascade is a further factor, requiring the use of licensed drugs.
When it comes to supplements, vets are still in favour of brands, but less so - as the cascade is not a factor. On the issue of price differential, most vets felt that a premium of 10-25% is justifiable for a brand over a generic.
Jonathan Posner, Business Director at Masius said: "As well as the quantitative data, we also got some interesting qualitative comments as well. Looking at these, one can see a range of opinions - from the vets who value the easier client acceptance of brands, to those who feel that their professional care of the patient is paramount and that a generic should be used where it delivers the same benefit as a brand. Client ability to pay was also mentioned as a factor - a generic being more likely to lead to compliance for a client on a tight budget."
The fact that branded products come with better information and marketing support was agreed by the large majority (93%) of respondents.
All the participants in the survey were entered into a draw to win an iPad 2. The winner of the draw was Megan Wood MRCVS (pictured right) from Fife. She said: "The iPad is brilliant; I love it, and am a lucky lady!"
A new study, led by academics at the University of Bristol's School of Veterinary Sciences and published online in Applied Animal Behaviour Science, has investigated the occurrence of dog aggression towards people with a survey of UK dog owners.
Nearly 15,000 questionnaires were distributed to dog owners of which 4,000 were returned and used in the analysis.
The researchers found that:
The study highlighted that the majority of dogs showing aggression do so in just one of these situations. Researchers say this indicates that the common tendency to categorise dogs as either generally 'safe' or 'vicious' is a misconception, and that most dogs show aggression as a learnt response to particular situations.
Dr Rachel Casey, Senior Lecturer in Companion Animal Behaviour and Welfare, said: "Dog owners and members of the public need to be aware that any dog could potentially show aggression if it is anxious or feels threatened, even when it has never done so before.
"On the other hand, dogs which have shown aggressive signs in one situation are not necessarily 'dangerous' when in other contexts - an important consideration in the assessment of animals, such as in rehoming centres."
The study also compared the characteristics of those dogs reported to show aggression with those which had never done so. It was revealed that factors such as training classes attended, type of training method used, the sex and neuter status of dogs, the age category of owners, and the breed of dogs were all associated with the occurrence of aggression.
Different risk factors were found to be significant in statistical models examining aggression to family members and unfamiliar people. This suggests that different factors are important in the development of aggressive signs depending on the situation.
The research also highlighted that although general characteristics, such as breed type, are significant risk factors across large populations they explain only a small amount of the overall difference between aggressive and non-aggressive dogs. This suggests that it is not appropriate to evaluate the risk of aggressive behaviour in an individual dog using characteristics such as breed type.
Reference
Human directed aggression in domestic dogs (Canis familiaris): occurrence in different contexts and risk factors, Rachel A. Casey, Bethany Loftus, Christine Bolster, Gemma J. Richards, Emily J. Blackwell, Applied Animal Behaviour Science, published online 11 December 2013.
Dechra Veterinary Products, maker of the feline hyperthyroidism treatment Felimazole®, has launched a range of waiting room materials for practices to raise awareness with owners about the disease.
Using Dechra's cartoon cat, which already features in their client booklets on feline hyperthyroidism, the materials are intended to create a focal point in the waiting room, with factual posters detailing what feline hyperthyroidism is and the symptoms to look out for. Also included is a selection of display enhancers.
The new waiting room display has been designed to complement Dechra's existing materials: client booklets, the website www.hyperthyroidcat.co.uk, website posters and hand-out cards.
Matthew Olsen, product manager at Dechra Veterinary Products said: "Our complete range of materials makes it easier for practices to communicate with owners on the subject and will help owners better understand and manage hyperthyroidism in their cats".
Practices can order their pack of waiting room materials by contacting Dechra on 01743 441632 or email marketing@dechra.com.
Cornerstone Veterinary Clinic, which was founded by Peter Herold in 2011, currently employs a 15-strong team, who are all now practice owners and shareholders in the business.
Peter got the inspiration from reading about how Pennard Vets had become the world’s largest employee-owned practice in order to protect both its independence and core values.
He then contacted the directors at Pennard Vets, who helped guide him through the process.
Peter said: “After starting Cornerstone 11 years ago, we have developed a longstanding, loyal and dedicated team who are all very popular with our established client base across Belfast and beyond.
"I genuinely love Cornerstone, and so do our team and clients, and although I’m not ready to retire yet, the end of my professional life will come in the next decade, so I wanted to start planning for it.
“The obvious option would be to sell the practice to a corporate chain, but I knew that would change how we worked.
"There would be much more emphasis on profit levels, and we’d be forced to make decisions that we were uncomfortable with.
"We have an amazing team who are full of ideas about how to make Cornerstone even better and to guarantee a successful future, the practice needs to continue growing in a way that works for its people, our clients and their pets.
“When I read about Pennard Vets becoming an EOT, it immediately resonated with me, and I hoped it could be an option for Cornerstone.
"I then attended a webinar with speakers from Pennard Vets, and I kept in touch with them afterwards.
"They explained the set-up and how it benefits their team, as well as putting us in touch with specialists in EOTs.
"Ultimately it was Pennard Vets’ knowledge and enthusiasm that convinced me it was the right route for us.”
Peter added: “Our senior team at Cornerstone are all very skilled and share common values in relation to customer service, veterinary care and client charges, and it’s this ethos that makes us popular with clients.
“Making the business an EOT will ensure this continues by safeguarding the future of the business, whilst giving each member of the team the benefit of being a business owner without them having to buy in.
"It also means I can continue to work as a vet, but share the management side of the practice with the entire team who can help to make the important decisions, which is an exciting prospect for everyone involved.”
Matthew Flann from Pennard Vets said: “We became an EOT to maintain our independence and give everyone in our team both autonomy and a voice, as well as preserving our core values around compassion, client focus and continually improving everything we do.
"This came at a time when it’s increasingly difficult for vets to buy into practices and the traditional partner progression model no longer works, which makes EOTs even more appealing and a positive step for the profession as a whole.
“It’s been genuinely transformational for Pennard Vets, and we now regularly hear from practice owners who are exploring becoming an EOT.
"There are now several other successful businesses currently on the journey and when Peter contacted us, we were happy to offer our help and guidance.
"Cornerstone is a successful practice, with a highly skilled and dedicated team, so its independence is worth protecting, and becoming an EOT will give it a bright future.”
Alstoe Animal Health has introduced a new, palatable joint nutrient supplement for horses.
According to the company, the benefits of feeding equine joint nutrient supplements to assist with maintaining mobility and supporting health joint function has been well documented, but until now, their flavours have often had to be disguised by mixing them into the feed in an attempt to ensure compliance.
Easeflex Equine palatable pellets include alfalfa, an equine favourite which has been used in the USA for some time, and shown to be readily accepted by horses, without the need to mix with the feed.
Alstoe says Easeflex Equine contains high levels of glucosamine hydrochloride and chondroitin sulphate, which are important in the production of glycosaminoglycans, and which have chondroprotective properties that aid in the natural renewal of cartilaginous tissue. Easeflex Equine palatable pellets also include MSM (methyl-sulphonyl-methane), a source of bioavailable sulphur, a key component of connective tissue and important in the synthesis of articular cartilage. Antioxidants are also present to help prevent damage by free radicals, as well as the essential trace minerals, copper, zinc and manganese.
Easeflex Equine palatable pellets can be fed to horses, ponies and donkeys of any age. The company recommends initial daily feeding of a double loading quantity for the first four to six weeks, thereafter reducing to a maintenance level or as directed by the veterinary surgeon. The amount of pellets to be fed depends on the weight of the animal, one small scoop containing 28g of pellets can be a daily dose for a horse of up to 450kg. Easeflex Equine palatable pellets are available in 1.7kg and 4.54kg tubs.
There are 10 candidates standing in this year’s elections, including four existing Council members eligible for re-election and six candidates not currently on Council. They are:
Mr David Catlow MRCVS
Mr John C Davies MRCVS
Dr Mandisa Greene MRCVS
Miss Karlien Heyrman MRCVS
Professor John Innes FRCVS
Dr Thomas Lonsdale MRCVS
Dr Susan Paterson FRCVS
Mr Matthew Plumtree MRCVS
Mr Iain Richards MRCVS
Colonel Neil Smith FRCVS
Ballot papers and candidates' details have been posted to all veterinary surgeons eligible to vote and an email containing a link to a secure voting site unique to each member of the electorate has also been sent by Electoral Reform Services which runs the election on behalf of the College.
All votes must be cast, either online or by post, by 5pm on Friday 27 April 2018.
This year the College invited all election candidates to produce a video in which they answered up to two questions submitted directly to the RCVS from members of the electorate. All videos have been published on the RCVS website (www.rcvs.org.uk/vetvote18) and YouTube channel (www.youtube.com/rcvsvideos).
Key question themes this year included recruitment and retention, the College’s concerns investigation process and veterinary education. The list of accepted questions has also been published on the RCVS website.
The biographies and statements for each candidate in the RCVS Council election can be found at www.rcvs.org.uk/vetvote18.
Eleanor Ferguson, RCVS Registrar and Returning Officer for the election, said: "Last year we had a record number and proportion of the electorate vote in an RCVS Council election and we would once again stress the importance of voting to ensure that you have a say in the future direction of travel for the College and its policies."
Those who are eligible to vote but have not received either an email or ballot paper should contact Luke Bishop, RCVS Senior Communications Officer, on l.bishop@rcvs.org.uk.
The dog presented to the Neurology and Neurosurgery Service at Pride after the dog's GP vet had diagnosed a tumour.
The neurological examination was consistent with a thoracolumbar lesion and the X-rays showed a radiopaque mass with bony lysis on the third lumbar vertebral body.
Annette Wessmann, an EBVS European Specialist in Veterinary Neurology at Pride said: “We chose to do a CT scan based on examination and the X-rays.
“It confirmed the suspicion of a neoplastic lesion and ruled out other tumoral focus along the rest of the spine and other organs."
A customised titanium implant was designed for the dog's spine in collaboration with BETA Implants.
Rosario Vallefuoco, an RCVS and EBVS Small Animal Surgery Specialist and Head of Small Animal Surgery at Pride said: “It was a case of combining our experience with that of the engineers.
“The original implants had been designed for humans, and we had to imagine what would be required for a dog and work out at every step what changes we would have to make.”
The surgery took place in three different stages, the first being L3 vertebra skeletonization and dorsal lamina removal.
The second step was vertebral body removal.
Finally, the third step was vertebral reconstruction using the designed implants.
The whole procedure took six hours, and the dog was up and walking again within 12 hours.
Subsequent histopathology assessment of the mass confirmed osteosarcoma, so the surgery is being followed up with chemotherapy.
Following the success of the surgery, Pride Veterinary Referrals says it now hopes to help other dogs with similar conditions.
www.prideveterinaryreferrals.com
A research project funded by The Horse Trust has discovered that a racehorse's performance does not markedly change after it has recovered from a tendon injury.
The research was led by Bryan O'Meara, who is in the final year of a three year clinical training scholarship funded by The Horse Trust.
Mr. O'Meara carried out the research at Donnington Grove Veterinary Surgery in Newbury, under the supervision of epidemiologist Dr Tim Parkin from University of Glasgow.
Tendonitis is one of the most common musculoskeletal injuries in racehorses, with a prevalence of 11-30%, according to earlier research.
Mr. O'Meara examined the clinical records and racing histories of 400 racehorses who had been treated for superficial digital flexor (SDF) tendonitis injuries over a five year period (2003-2008).
The race records of horses affected by tendon injury were compared with 400 matched control horses that had never suffered SDF tendon injuries.
The controls were horses training in the same establishment at the time of injury and of the same age and sex as the case horse.
The research looked at the performance of the racehorses in races before and after treatment for the injury, and at the performance of the control horses before and after the treatment date. The Racing Post Rating (RPR), which is published by the Racing Post after every race, was used as a measure of performance.
Mr. O'Meara found that there was no significant difference in RPR before and after the treatment date in case and control horses.
According to The Horse Trust, this result is unexpected as in vitro studies have found that healed tendon tissue has reduced elasticity due to the presence of scar tissue. This suggests that a horse with a healed SDF tendon would need to work its muscles harder to compensate and would therefore be expected to have lower performance.
Mr. O'Meara said more research is needed to back-up his finding that performance isn't significantly affected by tendon injury: "It could be that using Racing Post Rating to measure performance isn't sensitive enough to pick up a change in the horse's performance. However, it's encouraging that there's no marked change in performance after a horse has recovered from a tendon injury. These findings show that there's no need to give up on a horse that has a tendon injury - they can still come back and perform well, or can be used for other, less demanding riding activities."
The research also found that there was no significant difference between case and control horses when returning to racing and completing three races. Only after completing five races, or three years post treatment, was a significant difference found between case and control horses. This finding is a step towards developing a more accurate assessment of tendon treatment. Outcome after five races or three years post treatment is a better indicator of the outcome of treatment.
Mr. O'Meara said: "At the moment, some tendon treatments state their success as the percentage of horses that return to racing after treatment. However, we've shown that there's no significant difference between case and control horses at this time. At the moment, there are a myriad of treatments available to treat tendonitis. Hopefully this finding will be used in further research to learn which treatments are most effective."
Mr O'Meara's research also found a link between SDF tendon injury and the racehorse competing at its maximum performance level: the case horses were significantly nearer to their pre-injury maximum performance level in the race immediately before injury (compared to matched controls), suggesting that they were competing nearer their individual maximum performance level when the SDF tendon injury occured.
Intervet /Schering-Plough Animal Health has announced plans for a third National Vaccination Month Campaign to take place in May.
The campaign, which is aimed at owners of unvaccinated animals, is being fronted by TV presenter and wildlife expert Chris Packham. Intervet / Schering-Plough says it hopes the initiative will counter falling rates of pet vaccination that have been seen since the credit crunch.
In the lead up to National Vaccination Month, the company will be running a pet health awareness national and regional PR campaign backed up by print and TV advertising.
Pet owners will be able to download a voucher for a discounted vaccination in May from http://www.nvmonline.co.uk/. As well as dogs, cats and rabbits, horses will be included in the scheme for the second time.
During the last National Vaccination Month in June 2009, 1022 surgeries participated nationwide and an additional 40,000 animals were vaccinated as a result - 8,000 up on the first campaign run in 2008. According to Intervet / Schering-Plough, many practices saw more than 100 vouchers being redeemed.
The 2009 campaign came after more than a quarter of vets surveyed by Intervet reported concerns about falling levels of vaccination because of the credit crunch. Following the recession and public fears over the deficit, there are concerns that pet owners will cut back even further.
Angus Robinson from Intervet / Schering-Plough Animal Health said: "Research shows that the main reason why people don't vaccinate their pets is a lack of awareness of disease risk. We are also concerned that given the current pressures on household budgets, more people are deciding to cut back on vaccinating their animals with the real risk that this may have a potential effect on levels of herd immunity in the longer term."
He added: "We listened to practices which took part in NVM 2009 and have invested in improving the website to offer a simpler system for surgeries to download and log vouchers for their clients. The site will also drive pet owners to participating vets more quickly. Social media has taken off in a big way since our first campaign in 2008 and we will also be using Facebook and Twitter this time to reflect that. We are hoping that this will reach younger pet owners as data from our last campaign showed that pet owners in their 20s and early 30s were the age group least likely to vaccinate their animals."
Jane Carter of the Drove Veterinary Hospital in Swindon said: "National Vaccination Month is a golden opportunity to communicate the key preventative healthcare messages to new and existing clients. There was a significant outbreak of parvovirus in our area last summer which got a lot of publicity so we are expecting people will really catch onto the campaign this time."
Intervet / Schering-Plough Animal Health veterinary customers planning to take part in National Vaccination Month 2011 can log onto www.nvmonline.co.uk to complete the registration process.
Fees will now be £340 for a UK-practising member, £170 for members practising outside the UK, £56 for non-practising vets under the age of 70, and free for non-practising vets over 70.
Restoration fees, charged in addition to retention fees, increase to £85 following voluntary removal, and £340 following removal for non-payment.
Lizzie Lockett, RCVS CEO, said: "This year we asked Council to agree a fee increase to help us prepare for unknowns such as Brexit, as well as fortify our proactive work to help support the professions.
"Over the past few years we have put increased resources into projects such as: Mind Matters, our mental health initiative; Vet Futures, our joint project with the British Veterinary Association; Vivet, our innovation hub; and our recently launched Leadership Programme. Unfortunately there has also been a rise in Disciplinary Committee hearings and we are having to allocate further funds to making our building fit for purpose, and so a small increase has been necessary.
"This still places us at the lower end of fees for regulatory bodies while providing a secure financial foundation."
Dechra Veterinary Products has launched Buprenodale, an opioid analgesic for cats, dogs and horses presented in a 10ml multi-dose vial.
Carol Morgan, Brand Manager said: "Following on from the introduction of Comfortan and Anesketin, our Buprenodale Multidose, 0.3 mg/ml solution for injection for dogs, cats and horses, is the latest addition to the portfolio.
"The active substance in Buprenodale is buprenorphine, the most commonly used opioid analgesic in small animal practice in the UK.
"Buprenodale Multidose joins a portfolio of Dechra products covering a wide range of species, different levels of analgesic efficacy and duration of action.
"The product is now available in a 10 ml multidose vial. It is suitable for post-operative analgesia in dogs and cats; post operative analgesia, in combination with sedation, in horses and potentiation of the sedative effects of centrally acting agents in the dog and horse."
For more information www.dechra.co.uk .
The Royal Veterinary College has carried out the first ever open-heart surgery to treat a stenotic tricuspid valve in a dog.
The three-year-old Labrador, Mabel, suffered from congenital tricuspid dysplasia. She was referred to cardiology specialists at RVC Small Animal Referrals where her tricuspid valve was found to be completely fused in the middle, with just two very small openings for her blood to flow through.
In a procedure that took a little over an hour, the RVC team examined and worked on the valve. The College reports that Mabel’s surgery was a success and her stenosis was relieved.
Mabel was subsequently found to have a moderate amount of regurgitation into the right atrial chamber, but after a few more days of additional monitoring at the RVC she was able to return home.
The surgery was carried out by Professor of Small Animal Surgery Dan Brockman at the Queen Mother Hospital for Animals. He was assisted by a team of RVC specialists to provide pre and post-operative care, including a perfusionist, a team of three anaesthetists, two surgery nurses, three surgeons and a cardiology veterinary specialist-in-training. In addition, Professor of Veterinary Cardiology Virginia Luis Fuentes and veterinary specialist-in-training Dr Rosie Payne were members of the Cardiology Service’s investigation into Mabel’s condition.
RVC students were also involved in the Mabel’s initial examinations at the hospital, providing them with an insight into the procedure. The examinations included cardiac ultrasound using the newest generation of cardiac ultrasound equipment, which is able to capture 3D and 4D images. The new ultrasound scanner was funded in part by the RVC’s charity, the Animal Care Trust.
After the surgery, the emergency and critical care (ECC) team and the Cardiology Service took over Mabel’s care, with Professor Brockman remaining involved. This saw up to four senior ECC clinicians, a number of veterinary specialists-in-training and half a dozen highly trained ECC technicians working in shifts around the clock to care for Mabel and ensure a good recovery.
According to the RVC, there have been previous attempts by veterinary surgeons to open stenotic valves with balloon valvuloplasty. However, because it is very difficult to tear the stenotic valve, this approach has not proved very successful. There is also a high risk when putting canines onto bypass. Canines have fragile blood vessels, and cannulae need to be inserted into several of these vessels, creating a danger that a major vessel tears.
Commenting on why the RVC team decided to perform this procedure at this point, and on Mabel, Dan said: "Lots of things fed into this decision. First and foremost, we had a patient whose pathology made surgery the best solution. I explained to the owner and was very honest that this procedure would be really breaking new ground. Based on what the human paediatric cardiac surgeons will do, and our limited experience of balloon-valvuloplasty suggests this is the best approach for these dogs
"The operation itself is risky, much worse than most other operations. In our hands, for this type of disease, we have about an 80% chance of getting them through the procedure. The owner has to gamble what life the dog has left against the promise of a more normal quality of life and life-span following the operation."
In relation to Mabel’s prognosis if the surgery had not been undertaken, Professor Luis Fuentes said: "It is likely that the signs of right-sided heart failure would have been more difficult to control. Her ability to exercise would have become less and less, and she would have also been at risk of having abnormal heart rhythms associated with the enlargement of the right atrium. Generally we expect them to develop more and more signs as the disease progresses. These are difficult cases to manage on a long-term basis with drugs. Her life expectancy would have been substantially reduced.
"I thought Mabel was almost a perfect candidate to have the procedure here as Dan has a lot of experience replacing tricuspid valves in dogs with tricuspid dysplasia. In those cases there is usually leaking, but Mabel’s case was unusual in that she has minimal leaking and she was most affected by the stenosis. That means you may not have to implant any additional valve structure."
Speaking two weeks after the operation, owner Annabelle Meek, from Melton Mowbray, said: "Mabel has just come back in from wandering around the perimeter of my garden for the first time since before the operation. It’s more than half an acre and she has been ambling around happily following a scent.
"I would like to thank absolutely everybody. It’s been an enormous team effort on all sides. Every single person I met at the RVC, from the man on the gate to all the hospital staff, was so friendly. After she came home Dan Brockman phoned me every day to see how she was doing. The RVC should be very proud of what they have done for Mabel."
The study titled “Diagnosis and treatment of gastro-oesophageal junction abnormalities in dogs with brachycephalic syndrome” included thirty-six client-owned brachycephalic dogs (French bulldogs, pug and English bulldogs) in a prospective, randomised trial.
Antacid treatment (omeprazole (1mg/kg PO q24 hours) and magaldrate (5-10mL/dog PO q8-12 hours)) was randomly prescribed in 18 dogs before and after surgery, while the other 18 dogs did not receive any gastrointestinal medical treatment.
Digestive clinical signs and gastro-oesophageal junction abnormalities (GJA) were assessed and scored at presentation, at the time of surgery and at recheck. GJA were assessed during endoscopy in standard conditions, as well as during endotracheal tube obstruction. All endoscopic procedures were recorded and reviewed by a single, blinded reviewer.
In order to assess whether endotracheal tube obstruction manoeuvre accurately detects GJA, the procedure was also performed during the examination of the gastro-oesophageal junction in a group of 10 control dogs. Control dogs were healthy or had diseases that were not expected to interfere with gastro-oesophageal junction dynamics, and were anaesthetised for independent purposes.
Dr Emilie Vangrinsven, corresponding author for the paper said: "Although results of multivariate analysis failed to demonstrate a direct effect of antacid treatment, a significant interaction between antacid treatment status and improvement of digestive clinical score throughout the endoscopies was present, meaning that treated animals seem to improve faster and have lower clinical scores after surgery than untreated animals. Furthermore, a significant improvement in GJA-obstruction score was present in the treatment group only.
"In contrast to standard endoscopy, the obstruction manoeuvre during endoscopy allowed detection of GJA in dogs, even in the absence of clinical signs. We were concerned that the obstruction manoeuvre may induce false positive results for the diagnosis of dynamic GJA; in the control group, GJA during obstruction manoeuvre were found to be negligible suggesting that this technique does not significantly overestimate the presence of GJA.”
Nicola Di Girolamo, Editor of JSAP said: "Based on this study, antacid treatment administered to brachycephalic dogs undergoing surgery may be beneficial. It should be noted that a direct influence of antacid treatment on digestive clinical and lesion scores could not be significantly demonstrated, which may have been because of the lack of an actual difference, or as a result of the small sample size.”
The full article can be found in the March issue of the Journal of Small Animal Practice and can be read online here: https://www.onlinelibrary.wiley.com/doi/10.1111/jsap.13279
Photo: Professor Ian Ramsey